Vallon Pharmaceuticals Inc and Grit Bio Inc Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators Call Transcript
Hello, and welcome to the Vallon Pharmaceuticals and GRI Bio conference call and webcast. At this time, I'd like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations, or future projections.
These are forward-looking statements and involve risks and uncertainties. Forward looking statements on this call are made pursuant to the Safe Harbor provisions of the federal securities laws and are based on Vallon current expectations and actual results can differ materially. As a result, you should not place undue reliance on any forward-looking statements.
Some of the factors that could cause actual results to differ materially from those contemplated by such forward-looking statements are discussed in the periodic reports, Vallon files, with the Securities and Exchange Commission.
These documents are available on the Investor section of the company's website and on the Securities and Exchange Commission's website. We encourage you to review these documents carefully.
Joining us for the call today is David Baker
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
